Residential College | false |
Status | 即將出版Forthcoming |
Platelets Are Versatile Cells: Implications in Drug Developments Against Immune-Mediated Thrombocytopenia and Ischemic Stroke | |
ZHENG WENHUA | |
2024-09-19 | |
Size of Audience | 100 |
Type of Speaker | Session Chair |
Abstract | Platelets are small anucleate cells in blood circulation. Platelet adhesion and aggregation at the site of vascular injury are essential events to stop bleeding (hemostasis). However, the similar biological process of hemostasis may lead to vessel occlusion and pathogenic consequences (thrombosis). Thrombotic disorders in coronary and cereberal arteries are the most common mechanisms of heart attack and stroke.Recent studies also established that platelets are versatile cells, which actively contribute to inflammation, immune response and thrombo-inflammatory diseases (e.g.reperfusion injury in ischemic stroke). It has been documented for more than half century that fibrinogen is required for platelet aggregation, but we found that platelet aggregation still occur in mice lacking fibrinogen in intravital microscopy thrombosis model and established“fibrinogen-independent”platelet aggregation, in which platelet receptor GPIba (albβ3 integrin) is essential. We also found platelet receptor GPIba - von Willebrand factor (VWF) interaction mediates platelet adhesion and vessel occlusion, particular at high shear. Interestingly, although several drugs have been developed against GPHbIHa, no drug for patients has been available against GPIba.This presentation will introduce platelet versatilities and discuss potential new drugs in controlling immune-mediated thrombocytopenia (ITP and fetal and neonatal alloimmune thrombocytopenia) and thrombosis (ischemic stroke /other cardiovascular diseases). |
Conference Date | 2024-09-19 |
Conference Place | 澳门大学E12-G004 |
Language | 英語English |
Document Type | Presentation |
Collection | DEPARTMENT OF PHARMACEUTICAL SCIENCES |
Recommended Citation GB/T 7714 | ZHENG WENHUA. Platelets Are Versatile Cells: Implications in Drug Developments Against Immune-Mediated Thrombocytopenia and Ischemic Stroke, 2024-09-19. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment